Synovial distribution of "systemically" administered acetylsalicylic acid in the isolated perfused equine distal limb.
Authors: Friebe Maren, Schumacher Stephan, Stahl Jessica, Kietzmann Manfred
Journal: BMC veterinary research
Summary
# Editorial Summary: Acetylsalicylic Acid Distribution in Equine Synovial Fluid When farriers, vets and equine physiotherapists manage joint inflammation, understanding drug bioavailability at the site of pathology is crucial—particularly for competition horses where detecting prohibited substances matters. Friebe and colleagues employed an innovative ex vivo model using isolated perfused equine distal limbs combined with published plasma concentration data to determine whether systemically administered acetylsalicylic acid (ASA) and its active metabolite salicylic acid (SA) actually reach therapeutic levels within the fetlock joint. Using microdialysis coupled with high-performance liquid chromatography, the researchers measured synovial salicylate concentrations and compared them against established half-maximal effective concentrations (EC50 values) determined from equine whole blood assays. This approach sidesteps ethical concerns inherent in live animal experimentation whilst providing robust pharmacokinetic data directly relevant to clinical practice, particularly given that SA is the only NSAID with established detection thresholds in equine sport. The findings have direct implications for dosing protocols, competition regulations, and understanding whether systemic ASA administration provides meaningful anti-inflammatory benefit at the joint level—information essential for practitioners advising on both therapeutic efficacy and compliance with equine sports regulations.
Read the full abstract on PubMed
Practical Takeaways
- •Systemic ASA does achieve therapeutically relevant concentrations in the fetlock joint, supporting its use for joint-related inflammation in horses
- •This ex vivo model provides a framework for understanding drug bioavailability to equine joints without requiring animal experiments, useful for evaluating other systemic treatments
- •For competition horses, understanding synovial salicylate kinetics is important given that threshold plasma and urine levels exist for equine sports testing
Key Findings
- •Synovial salicylate concentrations achieved anti-inflammatory threshold levels following systemic ASA administration in the isolated perfused equine distal limb model
- •Microdialysis combined with HPLC successfully quantified acetylsalicylic acid and salicylic acid distribution into equine joint fluid
- •Synovial drug penetration was sufficient to reach pharmacologically active concentrations despite systemic administration